Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Advanced Proteome Therapeutics Raises US$0.04 Million In Venture Financing 12
Partnerships 13
Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 13
Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 14
Licensing Agreements 15
Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 15
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 16
Equity Offering 17
Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 17
Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 18
Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 19
Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 20
Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 21
Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 23
Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 24
Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 25
Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 26
Advanced Proteome Therapeutics Completes Private Placement Of Shares For US$0.2 Million 27
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.7 Million 28
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.3 Million 29
Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For US$0.2 Million 30
Advanced Proteome Therapeutics Corp – Key Competitors 31
Advanced Proteome Therapeutics Corp – Key Employees 32
Advanced Proteome Therapeutics Corp – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Corporate Communications 34
Jul 31, 2017: Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update 34
Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team 35
Government and Public Interest 36
Apr 15, 2016: Advanced Proteome Therapeutics Embarks Upon a Major Antibody Initiative 36
Product News 37
Nov 29, 2016: APC Invents Quantitative Method for Assessing Pattern of Antibody Labeling Impacting the Emerging, Rapidly Growing Market for Antibody-Drug Conjugates (ADC) 37
Other Significant Developments 38
Jul 18, 2016: Advanced Proteome Therapeutics Formulates Strategic Plan Featuring Novel Antibody Program 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Advanced Proteome Therapeutics Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Advanced Proteome Therapeutics Raises US$0.04 Million In Venture Financing 12
Advanced Proteome Therapeutics Expands Agreement with National Research Council of Canada 13
Advanced Proteome Therapeutics Enters into Agreement with Heidelberg Pharma 14
Glenmark Pharma Enters into Licensing Agreement with Advanced Proteome Therapeutics 15
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 16
Advanced Proteome Therapeutics to Raise USD0.4 Million in Private Placement of Shares 17
Advanced Proteome Therapeutics Raises USD0.3 Million in Rights Offering of Units 18
Advanced Proteome Therapeutics Raises USD0.1 Million in First Tranche of Private Placement of Units 19
Advanced Proteome Therapeutics to Raise USD0.2 Million in Private Placement of Shares 20
Advanced Proteome Therapeutics Raises USD0.2 Million in Private Placement of Units 21
Advanced Proteome Therapeutics Raises USD0.4 Million in Private Placement of Shares upon Exercise of Warrants 23
Advanced Proteome Therapeutics Raises USD0.6 Million in Private Placement of Units 24
Advanced Proteome Therapeutics Raises USD0.24 Million in Private Placement of Units 25
Advanced Proteome Therapeutics Raises USD0.17 Million in Private Placement of Units 26
Advanced Proteome Therapeutics Completes Private Placement Of Shares For US$0.2 Million 27
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.7 Million 28
Advanced Proteome Therapeutics Completes Private Placement Of Units For US$0.3 Million 29
Advanced Proteome Therapeutics Completes First Tranche Of Private Placement Of Units For US$0.2 Million 30
Advanced Proteome Therapeutics Corp, Key Competitors 31
Advanced Proteome Therapeutics Corp, Key Employees 32
Advanced Proteome Therapeutics Corp, Subsidiaries 33
【免責事項】
http://www.globalresearch.jp/disclaimer